Home > News > Gene technology moves forward at Mirus Bio
July 30th, 2007
Gene technology moves forward at Mirus Bio
Mirus later developed two methods for delivery intravenously via the veins, similar to administering an IV. Such a procedure can be done in 10 to 15 minutes, and is similar to giving blood, except that the material goes into the body rather than being withdrawn.
The first, "hydrodynamic intravascular injection," involves pressurized delivery of nucleic acids through the bloodstream to surrounding cells and tissues. This enables regional delivery to a limb or other targeted area of the body.
The second delivery platform involves nanoparticle formulations that are delivered via a standard IV injection -- no pressure is involved -- and can be targeted to specific tissues and cells without being limited to the area of injection.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
New imaging agent provides better picture of the gut July 30th, 2014
Zenosense, Inc. July 29th, 2014
Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014
Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method July 31st, 2014
Pressure probing potential photoelectronic manufacturing compound July 31st, 2014
NanoScience: Giants of the Infinitesimal July 31st, 2014
From Narrow to Broad July 30th, 2014